scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00795-017-0177-4 |
P698 | PubMed publication ID | 29280012 |
P2093 | author name string | Hirohisa Yano | |
Jun Akiba | |||
Masamichi Nakayama | |||
Sachiko Ogasawara | |||
Ken Nakamura | |||
Jingo Kusukawa | |||
Yoshiki Naito | |||
Yushi Abe | |||
P2860 | cites work | Overexpression of autophagy-related 16-like 1 in patients with oral squamous cell carcinoma | Q87441930 |
Identification and characterization of a novel bacterial sulfite oxidase with no heme binding domain from Deinococcus radiodurans | Q24537742 | ||
HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. | Q24815236 | ||
Molecular basis of sulfite oxidase deficiency from the structure of sulfite oxidase | Q27748778 | ||
Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
Essential role of conserved arginine 160 in intramolecular electron transfer in human sulfite oxidase | Q28211144 | ||
Hepatic sulfite oxidase. Congruency in mitochondria of prosthetic groups and activity | Q28240119 | ||
Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature | Q28270461 | ||
Why do cancers have high aerobic glycolysis? | Q28290710 | ||
The mutational landscape of head and neck squamous cell carcinoma | Q29614654 | ||
Novel insight into mutational landscape of head and neck squamous cell carcinoma | Q30441193 | ||
FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity | Q31124204 | ||
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study | Q33357032 | ||
Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance | Q33593026 | ||
Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia | Q33746724 | ||
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer | Q33845160 | ||
Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma | Q33869708 | ||
Sodium arsenite dependent protein expression analysis on human embryonic carcinoma (NCCIT) cell line | Q34021358 | ||
Expression of Cyr61 (CCN1) in human oral squamous cell carcinoma: An independent marker for poor prognosis | Q34138515 | ||
Oral cancer and precancerous lesions | Q34525597 | ||
KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer | Q34544971 | ||
Cancer's molecular sweet tooth and the Warburg effect. | Q34566915 | ||
Prenatal diagnosis of molybdenum cofactor deficiency and isolated sulfite oxidase deficiency | Q35047890 | ||
Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma | Q35125330 | ||
A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma | Q35281526 | ||
Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line | Q35972903 | ||
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis | Q36020872 | ||
Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma | Q36095943 | ||
Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma | Q36252665 | ||
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. | Q37083238 | ||
Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. | Q37489722 | ||
The prognostic and staging implications of bone invasion in oral squamous cell carcinoma. | Q37857786 | ||
Squamous cell carcinoma and precursor lesions: clinical pathology | Q37903903 | ||
Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma | Q38943073 | ||
The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients | Q39122749 | ||
Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma. | Q39558101 | ||
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma. | Q39696941 | ||
Prognostic and predictive factors in breast cancer by immunohistochemical analysis. | Q40866567 | ||
Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma. | Q40978367 | ||
Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma | Q41324942 | ||
miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules | Q41984092 | ||
Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients | Q42153424 | ||
Clinicopathologic features of oral squamous cell carcinoma: do they vary in different age groups? | Q42219643 | ||
Immunohistochemical study of CD44s expression in oral squamous cell carcinoma-its correlation with prognostic parameters | Q42943418 | ||
Causes of oral cancer--an appraisal of controversies | Q43234001 | ||
SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma | Q45391014 | ||
Isolated sulfite oxidase deficiency: MR imaging features | Q46702731 | ||
Analysis of clinicopathological risk factors for locoregional recurrence of oral squamous cell carcinoma - Retrospective analysis of 517 patients | Q47292614 | ||
Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma. | Q48233207 | ||
Elevated TARP promotes proliferation and metastasis of salivary adenoid cystic carcinoma. | Q50915772 | ||
An Immunohistochemical Analysis of PD-L1 Protein Expression in Surgically Resected Small Cell Lung Cancer Using Different Antibodies and Criteria. | Q51675103 | ||
Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. | Q51764303 | ||
The prognostic significance of histological features in oral squamous cell carcinoma. | Q51822378 | ||
miR-1193 Suppresses the Proliferation and Invasion of Human T-Cell Leukemia Cells Through Directly Targeting the Transmembrane 9 Superfamily 3 (TM9SF3). | Q52882743 | ||
Lipoprotein lipase in chronic lymphocytic leukaemia - strong biomarker with lack of functional significance. | Q53116985 | ||
The gene expression profile of extraskeletal myxoid chondrosarcoma. | Q53673930 | ||
Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12. | Q53923250 | ||
Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue | Q73121430 | ||
Prognostic factors in betel and tobacco related oral cancer | Q74444049 | ||
Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas | Q79353541 | ||
S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity | Q81449789 | ||
S100A2, a potential marker for early recurrence in early-stage oral cancer | Q81579225 | ||
Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome | Q84905965 | ||
Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study | Q87286269 | ||
P921 | main subject | carcinogenesis | Q1637543 |
P577 | publication date | 2017-12-26 | |
P1433 | published in | Medical Molecular Morphology | Q26842452 |
P1476 | title | SUOX is negatively associated with multistep carcinogenesis and proliferation in oral squamous cell carcinoma |
Q91813496 | LncRNA MIR503HG inhibits cell migration and invasion via miR-103/OLFM4 axis in triple negative breast cancer | cites work | P2860 |
Search more.